CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

Current stock price

2.69 EUR
-0.01 (-0.37%)
Last:

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • CTAC had positive earnings in the past year.
  • In the past year CTAC had a positive cash flow from operations.
  • Each year in the past 5 years CTAC has been profitable.
  • Each year in the past 5 years CTAC had a positive operating cash flow.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

1.2 Ratios

  • With an excellent Return On Assets value of 7.74%, CTAC belongs to the best of the industry, outperforming 83.56% of the companies in the same industry.
  • CTAC's Return On Equity of 16.41% is fine compared to the rest of the industry. CTAC outperforms 75.34% of its industry peers.
  • The Return On Invested Capital of CTAC (9.71%) is better than 60.27% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CTAC is below the industry average of 12.44%.
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROIC 9.71%
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of CTAC (2.86%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CTAC has declined.
  • CTAC has a worse Operating Margin (2.63%) than 72.60% of its industry peers.
  • CTAC's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CTAC (35.24%) is worse than 63.01% of its industry peers.
  • In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, CTAC has about the same amount of shares outstanding.
  • Compared to 5 years ago, CTAC has more shares outstanding
  • The debt/assets ratio for CTAC has been reduced compared to a year ago.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.98 indicates that CTAC is not in any danger for bankruptcy at the moment.
  • CTAC has a Altman-Z score of 3.98. This is amongst the best in the industry. CTAC outperforms 83.56% of its industry peers.
  • A Debt/Equity ratio of 0.16 indicates that CTAC is not too dependend on debt financing.
  • The Debt to Equity ratio of CTAC (0.16) is better than 73.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 3.98
ROIC/WACC1.45
WACC6.69%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.10 indicates that CTAC should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.10, CTAC is not doing good in the industry: 61.64% of the companies in the same industry are doing better.
  • CTAC has a Quick Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTAC.AS Growth Analysis

3.1 Past

  • The earnings per share for CTAC have decreased by -7.93% in the last year.
  • CTAC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.95% yearly.
  • CTAC shows a small growth in Revenue. In the last year, the Revenue has grown by 1.11%.
  • CTAC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.56% yearly.
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%

3.2 Future

  • The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
  • Based on estimates for the next years, CTAC will show a small growth in Revenue. The Revenue will grow by 7.04% on average per year.
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.76, which indicates a very decent valuation of CTAC.
  • CTAC's Price/Earnings ratio is rather cheap when compared to the industry. CTAC is cheaper than 84.93% of the companies in the same industry.
  • CTAC is valuated cheaply when we compare the Price/Earnings ratio to 26.17, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 8.11 indicates a reasonable valuation of CTAC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CTAC indicates a somewhat cheap valuation: CTAC is cheaper than 79.45% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CTAC to the average of the S&P500 Index (23.05), we can say CTAC is valued rather cheaply.
Industry RankSector Rank
PE 10.76
Fwd PE 8.11
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 87.67% of the companies in the same industry are more expensive than CTAC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.01
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.67
PEG (5Y)3.65
EPS Next 2Y7.74%
EPS Next 3Y0%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CTAC.AS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.14%, CTAC is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.76, CTAC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, CTAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.14%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • CTAC pays out 28.82% of its income as dividend. This is a sustainable payout ratio.
DP28.82%
EPS Next 2Y7.74%
EPS Next 3Y0%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (4/2/2026, 7:00:00 PM)

2.69

-0.01 (-0.37%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.23%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap38.06M
Revenue(TTM)188.71M
Net Income(TTM)5.40M
Analysts80
Price Target2.87 (6.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.14%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP28.82%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.36%
Valuation
Industry RankSector Rank
PE 10.76
Fwd PE 8.11
P/S 0.2
P/FCF N/A
P/OCF 60.51
P/B 1.16
P/tB 5.33
EV/EBITDA 4.01
EPS(TTM)0.25
EY9.29%
EPS(NY)0.33
Fwd EY12.32%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY1.65%
SpS13.34
BVpS2.33
TBVpS0.5
PEG (NY)0.67
PEG (5Y)3.65
Graham Number3.62
Profitability
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROCE 12.62%
ROIC 9.71%
ROICexc 11%
ROICexgc 42.74%
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
FCFM N/A
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
ROICexc(3y)12.83%
ROICexc(5y)13.89%
ROICexgc(3y)121.73%
ROICexgc(5y)145.43%
ROCE(3y)13.49%
ROCE(5y)14.56%
ROICexgc growth 3Y-18.29%
ROICexgc growth 5Y-22.64%
ROICexc growth 3Y-9.77%
ROICexc growth 5Y-4.88%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
F-Score6
Asset Turnover2.71
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.52
Cap/Depr 28.44%
Cap/Sales 0.81%
Interest Coverage 13.63
Cash Conversion 6.08%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 3.98
F-Score6
WACC6.69%
ROIC/WACC1.45
Cap/Depr(3y)42.32%
Cap/Depr(5y)33.13%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%
EBIT growth 1Y-10.74%
EBIT growth 3Y-10.42%
EBIT growth 5Y0.4%
EBIT Next Year118.18%
EBIT Next 3Y29.7%
EBIT Next 5YN/A
FCF growth 1Y-112.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.88%
OCF growth 3Y-52.08%
OCF growth 5Y-47.08%

CTAC NV / CTAC.AS Fundamental Analysis FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


What is the profitability of CTAC stock?

CTAC NV (CTAC.AS) has a profitability rating of 4 / 10.


How financially healthy is CTAC NV?

The financial health rating of CTAC NV (CTAC.AS) is 5 / 10.


Can you provide the expected EPS growth for CTAC stock?

The Earnings per Share (EPS) of CTAC NV (CTAC.AS) is expected to grow by 16.07% in the next year.